At his confirmation hearing on Wednesday before the Senate Finance Committee, Robert F. Kennedy Jr., Trump's controversial pick to lead the Health and Human Services, said rural hospitals will be a priority if he is confirmed as health secretary.
Kennedy told the committee that President Trump is determined to end the "hemorrhage of rural hospitals" through the use of AI and telemedicine, and...
Eleos, an AI behavioral healthcare company, announced it raised $60 million in a Series C funding round, bringing its total raise to more than $120 million.
The round was led by Greenfield Partners, with participation from existing investors F-Prime Capital, Eight Roads, Menlo Ventures and ION.
Additional investors include the Michael & Susan Dell Foundation, Union Tech Ventures and...
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.
The financing was led by the Wittington Innovation Fund, with participation from Toronto Innovation Acceleration Partners, Ontario Brain Institute and Ontario's...
Manas AI, an AI-driven drug discovery platform, has launched with $24.6 million in seed round in a round coled by General Catalyst and LinkedIn cofounder Reid Hoffman.
Greylock and other strategic investors participated in the round.
LinkedIn cofounder Reid Hoffman and Dr. Siddhartha Mukherjee, an oncologist, researcher and author, founded Manas AI.
WHAT IT DOES
Manas AI is a drug discovery...
DeepScribe, an AI-enabled clinical documentation tool for healthcare providers, is partnering with oncology-focused digital health company Flatiron Health to bring DeepScribe's AI documentation to clinicians that use Flatiron's OncoEMR, cloud-based electronic medical record platform.
According to the company, DeepScribe's ambient AI is "optimized for oncology by comprehending the workflow,...
Specialty care platform Lantern announced a partnership with digital substance use management platform Pelago to provide Lantern's clients with access to personalized substance use disorder treatment.
Starting next year, Lantern clients will gain access to Pelago’s substance use disorder (SUD) treatment via the company’s specialty care platform, which covers all substances and severities, such...
Tempus, an AI-powered data company involved in advancing precision medicine, launched olivia, an AI-enabled personal health concierge app aimed to empower patients by centralizing patients’ health data and making that data accessible and actionable through AI.
The app will allow patients to bring their health information into one combined platform.
Additionally, patients will be able to connect...
Atropos Health, a company translating real-world clinical data into real-world evidence (RWE) for decision making, is partnering with xCures, an AI-powered healthcare data retrieval company, to harness RWE-based insights to support patient care.
The aim of the partnership is to leverage AI, the Atropos Evidence Network and the xCures Platform in order to "develop and deploy validated prognostic...
Lindus Health, a company that conducts end-to-end clinical trials for the life sciences sector, announced it raised $55 million in Series B Funding.
The round was led by Balderton Capital with participation from Visionaries Club and existing investors Creandum, Firstminute and Seedcamp.
WHAT IT DOES
Lindus Health offers fully integrated CRO (contract research organization) services and in-house...
Research conducted on the International Space Station (ISS) may result in early cancer detection, advance treatments for neurodegenerative conditions and improve respiratory therapies.
Space Station (ISS) on SpaceX’s 31st Commercial Resupply Services (CRS) was on a mission for NASA.
SpaceX’s Dragon spacecraft contained close to 50 biotechnology, physical science and student research payloads...
